Abstract:
An occlusive coil delivery device includes an occlusive coil having a plurality of open pitched windings at a proximal end thereof, and a delivery wire assembly having a proximal tubular portion, a distal coil portion and a lumen, and a delivery wire adapter having a proximal end and a distal end. The delivery wire assembly having a delivery wire forming a first conductive path and extending through the lumen from a proximal end of the delivery wire assembly to a location distal of the distal coil portion, and a second conductive path formed by the proximal tubular portion and distal coil portion. The distal end of the adapter comprising a plurality of fingers configured to interface between adjacent open pitched windings of the proximal end of the occlusive coil, with the proximal end of the delivery wire adapter secured to a distal portion of the delivery wire.
Abstract:
PROBLEM TO BE SOLVED: To provide compositions and methods for repairing and regenerating cartilage defects which overcome the problems associated with the currently available methods and compositions. SOLUTION: The present invention provides the methods of repairing and regenerating cartilage tissue by administering into the cartilage or into the area surrounding the cartilage a composition comprising a therapeutically effective amount of a morphogenic protein. In some embodiments, the present invention provides the method of repairing a cartilage defect in a patient comprising the step of administering into the cartilage or into the area surrounding the cartilage the composition comprising a therapeutically effective amount of the morphogenic protein. The present invention also provides the method of repairing or regenerating a cartilage defect in a patient comprising the step of administering into the cartilage or into the area surrounding the cartilage the composition comprising a therapeutically effective amount of the morphogenic protein. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a cot bed for an ambulance which is equipped with lifting mechanism which makes the rise and fall of a stretcher easy. SOLUTION: There are provided a base which is supported by a wheel 14 as necessary and a stretcher which is moved up and down by power lifting mechanism which is arranged at a predetermined position between the base and the stretcher. A cot bed for an ambulance 10 also has radio communication capacity which makes communication easy between the cot bed for the ambulance and a loading system on the ambulance and makes wireless troubleshooting easy through a handheld wireless unit. The cot bed for the ambulance also has a head part 197 which stretches in a longitudinal direction. The cot bed for the ambulance also has some accessories such as an accessory hook which is placed on the lower side of a fowler and a foldable porch accessory which is fixed on the contractible head part and a stretcher frame 17. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
The present invention is directed to sustained release formulations of biologic agents which permit persistent bioavailability. Preferred biologic agents include bone morphogenetic proteins. Diseases susceptible to amelioration and/or treatment with the formulations of the present invention include skeletal tissue diseases such as, but not limited to, osteoarthritis and other osteochondral diseases. The sustained release formulations of the present invention are especially suitable for treatment of minimally-vascularized or non-vascularized tissue sites such as, but not limited to, intra joint, interarticular, or intraminiscal sites.
Abstract:
PROBLEM TO BE SOLVED: To provide pharmaceuticals for promoting the survival or growth, or inhibiting the death or degeneration, of mammalian cells (particularly neural cells). SOLUTION: A synergistic effect of OP/BMP morphogens in combination with GDNF/NGF neurotrophic factors in promoting the survival or growth, or inhibiting the death or degeneration, of mammalian cells (particularly neural cells), which express OP/BMP-activated serine/threonine kinase receptors and GDNF/NGF-activated tyrosine kinase receptors, is disclosed. Also disclosed are new methods for the in vivo and in vitro treatments of such cells, including in vivo treatments for mammals afflicted with, or at imminent risk of, damage or injury to such cells, as well as new pharmaceutical preparations for such in vivo and in vitro treatments. COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
The invention provides modified proteins and DNAs of the TGF-beta superfamily including modified morphogenic proteins. The proteins of the present invention display altered biological or biochemical attributes. Specifically, the modified proteins are designed through substitutions of amino acids in the finger 2 sub-domain or exchanges of all or part of the finger 2 sub-domain of one TGF-beta superfamily member with the finger 2 sub-domain of another TGF-beta superfamily member.
Abstract:
PROBLEM TO BE SOLVED: To provide improved osteogenic devices and methods of use thereof for repair of bone defects, cartilage defects and/or osteochondral defects. SOLUTION: Disclosed herein are improved osteogenic devices and methods of use thereof for repair of bone and cartilage defects. The devices and methods promote accelerated formation of repair tissue with enhanced stability using less osteogenic protein than devices in the art. Defects susceptible to repair with the instant invention include, but are not limited to critical size defects, non-critical size defects, non-union fractures, fractures, osteochondral defects, subchondral defects, and defects resulting from degenerative diseases such as osteochondritis dissecans. COPYRIGHT: (C)2009,JPO&INPIT